Moreover, the flow cytometry findings of increased CD34+ cells in the peripheral blood of G-CSF-treated rats signify recruitment or mobilization of EPCs after G-CSF treatment and provide another therapeutic implication for G-CSF-mobilized EPCs, i.e., in the attenuation of the delayed tPA-induced HT. The gene discussed is CD34; the disease is hematocrit.